anmelden
25 € WM-Startbonus auf dein Cash-Konto
Stoxx Europe 50
5.383,38
PKT
+49,25
PKT
+0,92
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.02.23 | BBVA Neutral | Goldman Sachs Group Inc. | |
| 02.02.23 | Santander Buy | Goldman Sachs Group Inc. | |
| 02.02.23 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.02.23 | ING Group Buy | Goldman Sachs Group Inc. | |
| 02.02.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 02.02.23 | LOréal Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.02.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 02.02.23 | UniCredit Buy | Goldman Sachs Group Inc. | |
| 02.02.23 | Santander Sector Perform | RBC Capital Markets | |
| 02.02.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 02.02.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.02.23 | AB InBev SA-NV (Anheuser-Busch InBev) Overweight | JP Morgan Chase & Co. | |
| 02.02.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 02.02.23 | BBVA Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.02.23 | UBS Buy | Jefferies & Company Inc. | |
| 02.02.23 | BBVA Outperform | RBC Capital Markets | |
| 01.02.23 | BBVA Neutral | JP Morgan Chase & Co. | |
| 01.02.23 | UniCredit Buy | Jefferies & Company Inc. | |
| 01.02.23 | Deutsche Telekom Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.02.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.02.23 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 01.02.23 | Deutsche Telekom Outperform | Bernstein Research | |
| 01.02.23 | BBVA Neutral | JP Morgan Chase & Co. | |
| 01.02.23 | Rio Tinto Underweight | JP Morgan Chase & Co. | |
| 01.02.23 | ING Group Buy | Jefferies & Company Inc. | |
| 01.02.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.02.23 | Novartis Buy | Jefferies & Company Inc. | |
| 01.02.23 | GSK Hold | Jefferies & Company Inc. | |
| 01.02.23 | BBVA Buy | Jefferies & Company Inc. | |
| 01.02.23 | BBVA Outperform | RBC Capital Markets | |
| 01.02.23 | BBVA Buy | UBS AG | |
| 01.02.23 | Novo Nordisk Sell | UBS AG | |
| 01.02.23 | GSK Sell | UBS AG | |
| 01.02.23 | Novartis Neutral | UBS AG | |
| 01.02.23 | UBS Neutral | Credit Suisse Group | |
| 01.02.23 | UniCredit Outperform | Credit Suisse Group | |
| 01.02.23 | UBS Outperform | RBC Capital Markets | |
| 01.02.23 | UBS Buy | Goldman Sachs Group Inc. | |
| 01.02.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.02.23 | GSK Underweight | JP Morgan Chase & Co. |